Lab Test and Tumor Markers in SSF Objective 7/13/2010. Part I Section 2: Site Specific Notes
|
|
- Cuthbert Anderson
- 6 years ago
- Views:
Transcription
1 LAB TESTS AND TUMOR MARKERS Part I Section 2: Site Specific Notes 2 Lab Test and Tumor Markers in SSF Objective To review and understand: Where and what to look for lab test results What does SI mean Prefixes and abbreviation Common Codes in Site Specific Factors Tumor Markers to site or histology specific schemas 3 1
2 Recording lab test and Tumor Markers Guide to registrars how to code lab test results Lab test should be coded in the CS SSFs Tumor markers and laboratory test may vary according to the lab and/or manufacturer When ever possible code the clinician s or pathologist s interpretations of the lab test In the absence of a doctor s interpretation of the test, if the reference range is available use this information to assign the code 4 Recording lab test and Tumor Markers Only when there is no clinician/pathologist interpretation of the lab test and no description of the reference range in the medical record should the registrar use background information listed in the tumor marker notes to code the SSF 5 Recording lab test and Tumor Markers Refer to the CS Manual for allowable codes Refer to the CS Manual for additional coding choices when the test results are not in the Medical Record 6 2
3 Lab Tests & Tumor Markers What does SI mean? French abbreviation for International System for standard units of measure Most SI values are based on kilogram, liter, or standard unit of time (seconds) A nanogram (ng) is one thousandth of a microgram (μg) A milliliter (ml) is one thousandth of a liter 7 Lab Tests & Tumor Markers What does SI mean? Lab value expressed in μg/l is equivalent to the same value expressed in ng/ml Some lab values, such as hormone levels, are recorded in International Units per Liter (IU/L) This is equivalent to miu/ml The equivalence of miu to ng varies according to what is measured SI Conversion: 1 μg/l = 1 ng/ml. For example, 1 ng of AFP is approximately equal to 1 miu Micrograms (μg) per liter may be shown as ug/l 8 urement_files/image021.jpg 3
4 Lab Tests & Tumor Markers Prefixes and abbreviations Units of Measure described and written in various ways in the medical record Unit of Measure dependent on the printer used to report Prefix micron (one millionth of a unit) scientific notation by the Greek Letter mu(μ) 10 Abbreviations for units of measurement Number Prefix Written 1,000,000 Mega M 1000 Kilo k 10 Deka da 1 (baseline) 1/10 Deci d 1/100 Centi c 1/1000 Milli m One millionth Micro m, u, or mc One billionth Nano n One trillionth Pico p One quadrillionth Femto f 11 Abbreviations for units of measurement Unit Abbrev Gram: gr Liter : L, l Unit : U Meter: M milli Equivalent meq Unit of substance: Mole, mol Examples Femtomole : fmol Microgram: ugr mcg μgr Milliliter : ml, ml 12 4
5 Common Codes in SSF Numeric Site Specific factor : Code 000 CEA, Chromogranin, CA 125, means a zero value on the test itself Code 979 (depending on the test) = 97.9 Code 980 Means that the true value was higher Code 988 Test was not performed (Remember Do not assume test was done Code 997 Ordered but no report in the MR Code 999 No information in the MR about the lab value 13 CA 19 9 Lab Value Appears in Schema: Stomach, Appendix, Ampulla of vater, Intraheptatic bile ducts, perihilar bile duct, Distal bile duct, all subsites of pancreas Normal reference range <37 U/mL FCDS & CoC Not Required in SSF s 14 CA 19 9 Lab Value Note 1: Carbohydrate Antigen 19 9 is a tumor marker that has value in the management of certain malignancies. Note 2: Record in Units/milliliter the highest CA 19 9 lab value recorded in the medical record prior to treatment. Example: A pretreatment CA 19 9 of 60 Units/milliliter (U/ml) would be recorded as
6
7 CEA (CARCINOEMBRYONIC ANTIGEN) Normal reference range Used in schemas: Stomach; Small Nonsmoker: < 2.5 ng/ml (SI: < intestine; Appendix carcinoma; 2.5 μg/l) Colon; Rectum; Ampulla of Vater; Perihilar bile ducts; Distal bile SI Conversion: 1 μg/l = 1 ducts; Ampulla of Vater ng/ml. Smoker: < 5 ng/ml (SI: < 5 Source documents: clinical lab μg/l) 1 μg/ml = 1 mg/l report, sometimes pathology or cytology report; H&P, operative report; consultant report; Ex: Colon/Rectal/Appendix SSF 1 Discharge summary FCDS NOT required CoC required 19 CEA (CARCINOEMBRYONIC ANTIGEN) Record both the reported value and the clinician s interpretation of the highest value prior to treatment. Code in nanograms per milliliter (ng/ml) the highest preoperative CEA lab value documented. If multiple CEA tests were performed prior to treatment, record the highest value. CEA Interpretation Code the corresponding interpretation of the CEA lab value as stated by the clinician. Use code 000 if there is a statement in the record that If there is no statement that the CEA is positive/elevated, ii negative/normal or the like, code the interpretation as Positive/elevated 020 Negative/normal 030 Borderline; undetermined whether positive or negative Notes: CEA is not a screening test and is not specific to colorectal cancer. Unlikely to be benign if > 10 ng/ml. Distant metastasis most likely if >100 ng/ml. 20 CHROMOGRANIN A (CGA) SSF 3 digit field implied decimal point Protein released by neuroendocrine cells Appears in Schemas: Pancreas (endocrine, all subsites); Neuroendocrine tumors Stomach; Small intestine; Appendix; Colon; Rectum; Ampulla of Vater Source documents: pathology report (immunohistochemistry stain) or clinical lab report (blood serum) Other names: Serum chromogranin A, CGA, chromogranin Chromagranin A is positive more often for WD NET (Carcinoid) than PD Record the higest CgA value prior to treatment Normal reference range Path report: Positive/negative Lab: ng/ml Results vary by laboratory Ex: NET Ampulla SSF 5 FCDS NOT required CoC required 21 7
8 HPV (HUMAN PAPILLOMA VIRUS) STATUS Appears in Schemas: All head and neck sites (carcinoma and melanoma) except major salivary glands and Other Pharynx ; Anus; Penis Source documents: pathology report (immunohistochemical staining), molecular analysis FCDS & CoC Not Required in SSF s Other names: human papillomavirus, HPV, HPV DNA test, human papillomavirus in situ hybridization, HPV hybrid capture test; high risk types: hr HPV, HRHPV 22 LDH, LDH VALUE, LDH UPPER LIMIT OF NORMAL Appears in Schemas: Melanoma Skin, Testis, Lymphoma Ocular Adnexa Source documents: clinical laboratory report; may be included in a liver or hepatic panel/profile, a cardiac panel, or a general metabolic panel of tests Other names: LD, Lactate dehydrogenase, lactase dehydrogenase, lactic acid dehydrogenase Normal reference range varies widely by laboratory, patient age, and the units of measurement Examples of reference range lab values: Lab A Total LDH U/L Lab B Total LDH U/L Lab C Total LDH U/L Lab D Total LDH U/L 23 LDH (MelanomaSkin)& Preorchiectomy LDH Interpretation (Testis) Melanoma Skin Testis Description Test not done; test not ordered and not performed Within normal limits Range 1: less than 1.5 times the upper limit of normal for that lab; for melanoma only: stated as elevated, NOS Range 2: 1.5 to 10 times the upper limit of normal for that lab Range 3: more than 10 times the upper limit of normal for that lab Test ordered, but results not in chart See schema for additional code choices Melanoma skin SSF 4 Required by FCDS & CoC Testis SSF 10 Preorchiectomy LDH Interpretation Required by FCDS & CoC 24 8
9 LDH (Melanoma Skin) SSF4 For melanoma, an abnormal value (SSF4 codes ) MUST be documented by at least two separate tests obtained more than 24 hours apart, according to the AJCC Cancer Staging Manual Note: LDH may not be done for early stage melanomas. If so, code as
10 MITOTIC COUNT Appears in Schemas: FCDS & CoC Required GIST Appendix GIST Colon GIST Esophagus GIST Peritoneum GIST Rectum GIST Small Intestine GIST Stomach Melanoma Skin FCDS & CoC NOT Required NET Ampulla NET Colon NET Small Intestine NET Stomach NET Rectum Pancreas Head, Pancreas Body Tail, Pancreas Other Source documents: pathology report Other names: Mitotic rate, mitotic index (a ratio do not record this measurement), mitotic activity CoC Required Melanoma Choroid Melanoma Ciliary Body Melanoma Iris 28 Record the number of cells actively dividing as determined by the Pathologist The Count will vary according o the type of tumor Follow the Instructions in the SSF notes NET (ampulla, colon, rectum, small intestine, stomach): count per 10 high power fields (HPF*) or 2 square millimeters GIST (appendix, colon, esophagus, peritoneum, rectum, small intestine, stomach): count per 50 HPF* or 5 square millimeters Melanoma of skin: count per square millimeter Ocular melanoma (choroids, ciliary body, iris): count per 40 HPF* or 4 square millimeters * The usual high power is 40x magnification 29 This site specific factor is a three digit field with an implied decimal point between the second and third digits For example: Mitotic count is reported as.8 mitoses per 50 HPF for a GIST Colon tumor, record as 008 Mitotic rate is reported as 11 mitoses per 50 HPF for a GIST Colon, record as
11 31 32 Reference Collaborative Stage Data Collection System Coding Manual and Instructions Part I Section 2: Site Specific Notes VERSION INCORPORATING UPDATES THROUGH JANUARY 1,
LAB TESTS AND TUMOR MARKERS Part I Section 2: Site Specific Notes
LAB TESTS AND TUMOR MARKERS Part I Section 2: Site Specific Notes 2 Lab Test and Tumor Markers in SSF Objective To review and understand: Where and what to look for lab test results What does SI mean Prefixes
More informationCOLLABORATIVE STAGE DATA COLLECTION SYSTEM USER DOCUMENTATION AND CODING INSTRUCTIONS
COLLABORATIVE STAGE DATA COLLECTION SYSTEM USER DOCUMENTATION AND CODING INSTRUCTIONS Collaborative Stage Work Group of the American Joint Committee on Cancer Part I General Instructions Version 02.03.02
More informationGastrointestinal Stromal Tumors (GIST)
Collaborative Stage Version 2: GISTs and NETs Education and Training Team Collaborative Stage Data Collection System Version 2.02 Gastrointestinal Stromal Tumors (GIST) What are GISTs? Rare type of soft
More informationCANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume
More information2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Soft Tissue Sarcoma, Neuroendocrine Tumors (NET) and Gastrointestinal Stromal Tumors (GIST) Agenda Updates Soft Tissue Sarcoma Overview CSv2 MP/H
More informationGetting Specific About Site-Specific Factors
Getting Specific About Site-Specific Factors CS version 0203 Education and Training Team Overview CSv0202 to CSv0203 changes What are Site-Specific Factors? Types of Site-Specific Factors Examples Code
More informationCollaborative Stage Data Collection System (CSv2) Reporting Requirements Commission on Cancer (CoC) (Updated 4/8/ changes in red print)
Collaborative Stage Data Collection System (CSv2) Reporting Requirements Commission on Cancer (CoC) (Updated 4/8/2010 - changes in red print) Timing. Collaborative Stage version 2 must be used for all
More informationCollaborative Stage Data Collection System (CSv xx) Reporting Requirements Commission on Cancer (CoC)
Collaborative Stage Data Collection System (CSv 02.03.xx) Reporting Requirements Commission on Cancer (CoC) Timing. Collaborative Stage version 02.03.xx must be used for all cases diagnosed on or after
More informationKyle L. Ziegler, CTR. California Cancer Registry U.C. Davis Health System
Kyle L. Ziegler, CTR California Cancer Registry U.C. Davis Health System Overview New Data Items Reportability Clarifications New Coding Rules Grade ICD-O-3 Changes Collaborative Stage v0205 2 New Data
More informationThere is a Reason for Everything including Changes
There is a Reason for Everything including Changes What & Why Who & When Overview A Closer look Introduction & Overview of Site-Specific Data Items A.K.A. SSDIs Let me introduce myself Colleen M. Grosso,
More informationCollecting Cancer Data: GIST/NET 1/9/14
Collecting Cancer Data: Gastrointestinal Stromal Tumor (GIST) Gastrointestinal Neuroendocrine Tumors (NET) 2013 2014 NAACCR Webinar Series January 9, 2014 Q&A Please submit all questions concerning webinar
More informationQ&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012
Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012 Q: Will sticky notes be transferrable from the previous electronic version of CS to the updated version? A: It is our
More informationCollecting Cancer Data: Pancreas
Collecting Cancer Data: Pancreas NAACCR 2011 2012 Webinar Series 1/5/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this
More informationMCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR
MCR: MANAGEMENT OF 2018 CHANGES By: Maricarmen Traverso-Ortiz MPH, CGG, CTR LEARNING OBJECTIVES Discuss a summary of the new changes for 2018 Overview of how the Maryland Cancer Registry is managing and
More informationNAACCR Webinar Series 1. Instructors Q&A 10/6/2011. Collecting Cancer Data: Larynx Including Mucosal Melanoma of Larynx.
NAACCR 2011 2012 Webinar Series Collecting Cancer Data: Larynx Instructors Shannon Vann, CTR Jim Hofferkamp, CTR 2 Q&A Please submit all questions concerning webinar content through the Q&A panel. 3 NAACCR
More informationCEA (CARCINOEMBRYONIC ANTIGEN)
(CARCINOEMBRYONIC ANTIGEN) 428 C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant
More informationAJCC 7th Edition Handbook Errata as of 9/21/10
5 81 Larynx ICD-O-3 Topography Codes Delete C32.3 Laryngeal cartilage 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.8 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.9 5
More informationSite-Specific Data Item (SSDI) Manual
Site-Specific Data Item (SSDI) Manual Effective with Cases Diagnosed 1/1/2018 and Forward Published May 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth
More informationSEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl
SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and
More informationSEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING
SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING OVERVIEW What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets Site Specific Data Items (SSDI) SEER Summary
More informationCarcinoembryonic Antigen
Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring
More informationBIO 137 Human Anatomy & Physiology I. Laboratory Manual. Laboratory #1: Measurements, Body Organization and Anatomical Systems
BIO 137 Human Anatomy & Physiology I Laboratory Manual Laboratory #1: Measurements, Body Organization and Anatomical Systems Lab Exercise 1 Measurements Body Organization Body Systems What you need to
More informationSite-Specific Data Item (SSDI) Manual
Site-Specific Data Item (SSDI) Manual Effective with Cases Diagnosed 1/1/2018 and Forward published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth
More informationVersion 2 Overview and Update CSv0202 to CSv0203
Version 2 Overview and Update CSv0202 to CSv0203 CS version 2 Education and Training Team What We ll Cover Rules changes and revisions CSv0202 to CSv0203 Sites with Major Changes Esophagus and Stomach
More information1 Size of Lymph Nodes Required 3883 LN Size 2. OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck
1 Size of Lymph Nodes Required 3883 LN Size 2 OBSOLETE - Extracapsular Extension, Lymph 3 Levels I-III, Lymph 3-7 Buccal Mucosa, Gum (3), Lip (3), Levels IV-V and Retropharyngeal Lymph Nodes Floor Mouth,
More informationANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
More informationTumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.
Tumour Markers What are Tumour Markers? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer
More informationSite-Specific Data Item (SSDI) Manual
Site-Specific Data Item (SSDI) Manual Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published February 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR
More information4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines
SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific
More informationLab Exercise 1. Getting Started with the Basics
Anatomy & Physiology Names:, Period date: Textbook Reference: See Chapter 1 Lab Exercise 1. Getting Started with the Basics Measurement Body Organization Body Systems What you need to be able to do to
More informationCODING PRIMARY SITE. Nadya Dimitrova
CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign
More information2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
More informationAccuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa:
Accuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa: 2010-2014 Amanda Kahl, MPH Mary Charlton, PhD, Nitin Pagedar, MD, MPH, Steven Sperry,
More informationTumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director
Tumor Markers Yesterday, Today & Tomorrow Steven E. Zimmerman M.D. Vice President & Chief Medical Director Tumor Marker - Definition Substances produced by cancer cells or other cells in response to cancer
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
More informationI.2 CNExT This section was software specific and deleted in 2008.
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I Changes and Clarifications 8th th Edition Revised May 2008 SECTION
More informationWhat s New for 8 th Edition
What s New for 8 th Edition KCR 2018 SPRING TRAINING Overview What s New New Chapters for 8 th Editions Chapters That Split in 8 th Edition Merged 8 th Edition Chapters Blanks vs Xs How to Navigate Through
More informationWe re on the Web! Visit us at VOLUME 19 ISSUE 1. January 2015
VOLUME 19 ISSUE 1 January 2015 We re on the Web! Visit us at www.kumc.edu/kcr January is National Cervical Cancer Screening Month. Cervical cancer begins in the lining of the cervix (organ connecting the
More informationColon and Rectum: 2018 Solid Tumor Rules
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Colon and Rectum: 2018 Solid Tumor Rules 1 Colon and Rectum Solid Tumor Rules Separate sections for: Introduction Changes from 2007 MP/H rules Equivalent
More informationQuiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.
Quiz 1 Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios. 1. 62 year old Brazilian female Race 1 Race 2 Spanish/Hispanic Origin 2. 43 year old Asian male born in Japan Race 1
More informationCase Scenario 1. Discharge Summary
Case Scenario 1 Discharge Summary A 69-year-old woman was on vacation and noted that she was becoming jaundiced. Two months prior to leaving on that trip, she had had a workup that included an abdominal
More informationFormat Of ICD-O Terms In Numerical List Each topographic and morphologic term appears only once The first listed term in Bold Type is the Preferred Te
Florida Cancer Data System International Classification of Diseases for Oncology ICD-O-3 1 Basic Concepts Primary Site/Topography Histology/Morphology Behavior Grade/Immunophenotype 2 ICD-O 3 Structure/Format
More informationICD-O-3 UPDATES - PENDING
ICD-O-3 UPDATES - PENDING FCDS Annual Meeting July 26, 2013 Sunrise, Florida Steven Peace, CTR ICD-O-3 Work Group ICD-O-3 WORK GROUP Name April Fritz, CTR Lynn Ries, MS Lois Dickie, CTR Linda Mulvihill,
More informationICD-O-3 UPDATES - PENDING
ICD-O-3 UPDATES - PENDING FCDS Annual Meeting July 26, 2013 Sunrise, Florida Steven Peace, CTR ICD-O-3 Work Group ICD-O-3 WORK GROUP Name April Fritz, CTR Lynn Ries, MS Lois Dickie, CTR Linda Mulvihill,
More information2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018
1 2018 Grade PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgements Donna Hansen, CCR Jennifer Ruhl, NCI SEER Introduction 3 Histologic Type vs. Grade Credit: Dr. Kay Washington
More informationAppendix H 2018 FCDS Required Site Specific Data Items (SSDIs)
Below is the short list of Site Specific Data Items (SSDI) Required by FCDS for 2018. The list may be subject to changes. FCDS requires only a subset of the 136 total SSDIs available to be reported as
More informationFCDS Annual Educational Conference Orlando, Florida July 28, Steven Peace, CTR
FCDS Annual Educational Conference Orlando, Florida July 28, 2017 Steven Peace, CTR 1 Outline 2018 Transition from CS SSFs to Individual Site Specific Prognostic Factor Fields (SSFs) Locating SSFs in the
More informationQ: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?
Q&A Session for Collecting Cancer Data: Ovary Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report? A: We reviewed both the
More informationCollaborative Staging
Slide 1 Collaborative Staging Site-Specific Instructions Prostate 1 In this presentation, we are going to take a closer look at the collaborative staging data items for the prostate primary site. Because
More informationGreater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14
Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Contents 14. Neuroendocrine Tumours 161 14.1. Diagnostic algorithm
More informationTesticular Malignancies /8/15
Collecting Cancer Data: Testis 2014-2015 NAACCR Webinar Series January 8, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching
More informationTruman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
More informationGrade Coding Instructions and Tables
Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth
More informationAnnual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
More informationHOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
More informationGrade Coding Instructions and Tables
Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward Published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth
More informationChecklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005
ChecklistTemplateVersions ChecklistTemplateVersion Ckey OfficialName VisibleText RevisionDate Checklist; Adrenal gland: 16.1000043 Resection Adrenal gland: Checklist; Ampulla of 17.1000043 Vater: Ampullectomy
More informationChange Log V1.3- v1.4
Change Log V1.3- v1.4 This document shows the changes that were made to the SSDI manual and the Grade manual for the SEER*RSA version 1.4 release on (Date TBD). SSDI Manual Section: General Instructions
More informationCOLON AND RECTUM SOLID TUMOR RULES ABSTRACTORS TRAINING
COLON AND RECTUM SOLID TUMOR RULES ABSTRACTORS TRAINING COLON AND RECTUM SOLID TUMOR RULES Separate sections for: Introduction Changes from 2007 MP/H rules Equivalent Terms Terms that are NOT Equivalent
More informationCoding Pitfalls 9/11/14
Coding Pitfalls 2013 2014 NAACCR Webinar Series September 11, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationCS Tumor Size. GISTStomach. Collaborative Stage for TNM 7 - Revised 01/27/2010 [ Schema ]
GISTStomach Collaborative Stage for TNM 7 - Revised 01/27/2010 [ Schema ] CS Tumor Size Note: the specific tumor size as documented in the medical record. If the ONLY information regarding tumor size is
More informationAMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING
AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING ATLAS EDITORS FREDERICK L. GREENE, m.d. Chair, Department of General Surgery Carolinas Medical Center Charlotte, North Carolina CAROLYN C. COMPTON,
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited
More informationGrade Coding Instructions and Tables
Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published February 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR
More informationEarly Cancer Care FAQ
If you need more information, you can call 6722 2293 (Mon-Fri, 9am-5pm), email our Financial Protection Specialists at financial2@ocbc.com or visit any of our OCBC branches. Q1. What is this Early Cancer
More informationEsophagus, Esophagus GE Junction, Stomach
Esophagus, Esophagus GE Junction, Stomach Education and Training Team Collaborative Stage Data Collection System Version v02.03 Learning Objectives Understand rationale behind changes and updates Understand
More informationS2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
More informationA Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR
A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR Survey Questions and Answers 250 Responses 2 Question #1 A gentleman
More informationEpidemiology in Texas 2006 Annual Report. Cancer
Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer
More informationTumor Immunology. Tumor (latin) = swelling
Tumor Immunology Tumor (latin) = swelling benign tumor malignant tumor Tumor immunology : the study of the types of antigens that are expressed by tumors how the immune system recognizes and responds to
More informationOriginal Article. Cancer December 1,
Analysis of Stage and Clinical/Prognostic Factors for Colon and Rectal Cancer From SEER Registries: AJCC and Collaborative Stage Data Collection System Vivien W. Chen, PhD 1 ; Mei-Chin Hsieh, MSPH 1 ;
More informationINFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
More informationNAACCR Webinar 2018 SeriesImplementations and Timelines
NAACCR 2015-2016 Webinar 2018 SeriesImplementations and Timelines August 8, 2017 Session 1 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session,
More informationCDC & Florida DOH Attribution
FCDS Annual Educational Conference Tampa, Florida July 19, 2018 Steven Peace, CTR 1 CDC & Florida DOH Attribution We acknowledge the Centers for Disease Control and Prevention, for its support of the Florida
More informationADVANCED ASSESSMENT Medical Math
ONTARIO BASE HOSPITAL GROUP ADVANCED ASSESSMENT Medical Math 2007 Ontario Base Hospital Group ADVANCED ASSESSMENT Medical Math AUTHOR Tim Dodd AEMCA, ACP Hamilton Base Hospital REVIEWERS/CONTRIBUTORS Rob
More informationUK CAA Oncology Certification Charts
UK CAA Oncology Certification Charts 1. Colorectal 2. Malignant Melanoma 3. Germ Cell Tumour of Testis 4. Renal Cell Carcinoma 5. Breast Carcinoma 6. Non-small Cell Lung Cancer Note: All Class 1 cases
More informationAmerican Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
More informationA Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files
A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files By Dr. Martin A. Whiteside Director, Office of Cancer
More informationCollaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ]
MelanomaSkin CS Tumor Size Collaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ] Code 000 No mass/tumor found Description 001-988 001-988 millimeters (code exact size in millimeters) 989 989 millimeters
More informationCancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
More informationNeuroendocrine Tumors
Neuroendocrine Tumors FCDS Annual Conference Boca Raton Marriott at Boca Center July 28, 2016 Steven Peace, BS, CTR Anatomy and Physiology of the (Neuro)Endocrine System WHO Classification, Tumor Grade
More informationData Harmonization Efforts Across the Cancer Staging System. Donna M. Gress, RHIT, CTR AJCC Technical Specialist
Data Harmonization Efforts Across the Cancer Staging System Donna M. Gress, RHIT, CTR AJCC Technical Specialist Objectives Describe efforts underway to harmonize data elements and concepts used in cancer
More information2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Eight Groups are Revised for 2018 Head & Neck Colon (includes rectosigmoid and rectum for cases diagnosed 1/1/2018 forward) Lung (2018 Draft not yet
More informationA patient s guide to understanding. Cancer. Screening
A patient s guide to understanding Cancer Screening Contents 04 06 10 12 Cancer Screening Who Should Go For Cancer Screening 05 Nasopharyngeal Carcinoma Colorectal Cancer 08 Lung Cancer Liver Cancer Breast
More informationThe European Commission s science and knowledge service. Joint Research Centre
The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What
More informationMetastatic esophageal cancer icd 10 code
Metastatic esophageal cancer icd 10 code Gogamz Menu Taxanes are conventional treatment for metastatic breast cancer (MBC); however, the solvents (e.g., ethanol and polyoxyethylated castor oil) employed
More informationNET / GIST / MEN. 2014/2015 FCDS Educational Webcast Series. October 16, Steven Peace, CTR
NET / GIST / MEN 2014/2015 FCDS Educational Webcast Series October 16, 2014 Steven Peace, CTR Anatomy and Physiology of the (Neuro)Endocrine System WHO Classification, Tumor Grade, Hereditary Syndromes
More informationCRITICAL ANALYSIS OF NEN GUIDELINES. G Pentheroudakis Associate Professsor of Oncology Medical School, University of Ioannina Chair, ESMO Guidelines
CRITICAL ANALYSIS OF NEN GUIDELINES G Pentheroudakis Associate Professsor of Oncology Medical School, University of Ioannina Chair, ESMO Guidelines DISCLOSURES NO CONFLICTS OF INTEREST TO DECLARE UPDATED
More informationColon, Rectum, and Appendix
Colon, Rectum, and Appendix 2011 Reporting Requirements and CSv02.03.02 NCCN/ASCO Treatment Guidelines by Stage FCDS 2011 Educational Webcast Series September 15, 2011 Steven Peace, CTR Presentation Outline
More informationColon, Rectum, and Appendix. Presentation Outline. Overview Tumor Characteristics
Colon, Rectum, and Appendix 2011 Reporting Requirements and CSv02.03.02 NCCN/ASCO Treatment Guidelines by Stage FCDS 2011 Educational Webcast Series September 15, 2011 Steven Peace, CTR Presentation Outline
More informationClinical Biochemistry Department City Hospital
Cancer Biochemistry and Tumour Markers Clinical Biochemistry Department City Hospital In this lecture Cancer basics Definition of Tumour Marker (TM) What is the perfect TM? History of TMs Examples of TMs
More informationA. Incorrect! The esophagus connects the pharynx and the stomach.
Human Physiology - Problem Drill 19: Digestive Physiology and Nutrition Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. This organ
More informationPancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)
Pancreas Quizzes Quiz 1 1. The pancreas produces hormones. Which type of hormone producing organ is the pancreas? a. Endocrine b. Exocrine c. Both A and B d. Neither A or B 2. Endocrine indicates hormones
More informationINFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
More informationCS Release Notes Version ORGANIZATION OF RELEASE NOTES
ORGANIZATION OF RELEASE NOTES The Release Notes are organized in the following manner: Manual Review for Recoding of Cases : General Coding Instructions Part I Section 2: Lab Tests, Tumor Markers, and
More informationMEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site
POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization
More informationAutomated Coding of Key Case Identifiers from Text-Based Electronic Pathology Reports
Automated Coding of Key Case Identifiers from Text-Based Electronic Pathology Reports George Cernile Artificial Intelligence in Medicine, Inc NAACCR 2017 Conference Albuquerque New Mexico, USA June 22,
More information7/29/ Education & Training Plan FCDS Webcast Series and VoIP Audio. Outline Education & Training Plan
2014-2015 Education & Training Plan FCDS Webcast Series and VoIP Audio 1 2 0 1 4-2 0 1 5 F C D S E D U C A T I O N & T R A I N I N G P L A N T R A I N I N G T O O L S A N D R E S O U R C E S G O T O M
More informationPANCREAS DUCTAL ADENOCARCINOMA PDAC
CONTENTS PANCREAS DUCTAL ADENOCARCINOMA PDAC I. What is the pancreas? II. III. IV. What is pancreas cancer? What is the epidemiology of Pancreatic Ductal Adenocarcinoma (PDAC)? What are the risk factors
More informationFast, automated, precise
Thermo Scientific B R A H M S / NSE Immunodiagnostic Assays Fast, automated, precise Neuroendocrine tumor markers on KRYPTOR Systems First and only fully automated CgA assay worldwide Shortest time to
More information